Safety and efficacy with alemtuzumab over 13 years in relapsing-remitting multiple sclerosis: final results from the open-label TOPAZ study
阿仑单抗治疗复发缓解型多发性硬化症13年的安全性和有效性:开放标签TOPAZ研究的最终结果
期刊:Therapeutic Advances in Neurological Disorders
影响因子:4.1
doi:10.1177/17562864231194823
Coles, Alasdair J; Achiron, Anat; Traboulsee, Anthony; Singer, Barry A; Pozzilli, Carlo; Oreja-Guevara, Celia; Giovannoni, Gavin; Comi, Giancarlo; Freedman, Mark S; Ziemssen, Tjalf; Shiota, Debora; Rawlings, Andreea M; Wong, Alana T; Chirieac, Magdalena; Montalban, Xavier